おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
GenomePrecision
company
About
GenomePrecision is a national economic and technological development zone.
- 251 - 500
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥100M
GenomePrecision has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Feb 18, 2019 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2019 | Series B | ¥100M | 2 | — | — | Detail |
| Mar 6, 2017 | Series A | — | 1 |
Sigma Square Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
GenomePrecision is funded by 2 investors.
Yizhuang Biomedical Mergers and Acquisition Funds
and Sigma Square Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
Sigma Square Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
